Yes, in PDD we're seeing dose dependency signal in the endpoint scores. It's good stuff. We're also seeing dependency on SIGMAR1 status (wt vs mut). I'm hoping we eventually are given SIGMAR1 status analysis for the Rett trials. Would be good to see dependency, since their were apparent non-responders.